Metformin Modified release Tablet 1000 mg

πŸ”Ή Metformin Modified Release (MR) Tablet 1000 mg – As Licensed


πŸ“„ Description:

Metformin Modified Release (MR) 1000 mg is a long-acting oral antidiabetic medicine from the biguanide class, designed for once-daily dosing with gradual release into the bloodstream. It controls high blood glucose levels in patients with Type 2 Diabetes Mellitus, particularly useful for those who experience gastrointestinal side effects with the immediate-release (IR) formulation.


πŸ’Š Prescription / Use:

  • Indications:
    • First-line treatment for Type 2 Diabetes Mellitus
    • Especially suitable for patients with:
      • Poor tolerance to IR Metformin
      • Need for once-daily dosing
    • Sometimes used off-label for Polycystic Ovary Syndrome (PCOS)
  • Dosage:
    • Usually 1000 mg once daily with evening meal
    • Can be titrated based on glycemic response (max: 2000 mg/day)
    • Swallow wholeβ€”do not crush or chew

πŸ”¬ Nature:

  • Class: Biguanide antihyperglycemic agent
  • Formulation: Modified-release (MR) or extended-release (XR) tablet
  • Appearance: Oblong or oval, film-coated tablet, often labeled “1000”
  • Mechanism:
    • Reduces hepatic glucose production
    • Increases insulin sensitivity
    • Delays glucose absorption in the gut
    • Minimal risk of hypoglycemia as monotherapy

🌟 Advantages:

  • Once-daily dosing improves adherence
  • Fewer gastrointestinal side effects compared to IR formulation
  • Weight-neutral or weight-reducing
  • Does not cause hypoglycemia when used alone
  • Improves fasting and postprandial glucose levels
  • Better patient tolerability

πŸ“¦ Common Packaging:

  • Blister packs or strips of 10 or 15 tablets
  • Also available in bottles (hospital use)
  • Clearly marked with strength and manufacturer details

🧊 Storage:

  • Store at room temperature (below 25Β°C)
  • Keep in a dry place, away from light and moisture
  • Do not use beyond expiry date

⚠️ Precautions:

  • Contraindicated in:
    • Renal impairment (eGFR <30 mL/min/1.73 mΒ²)
    • Acute metabolic acidosis
    • Severe liver dysfunction
  • Use caution in:
    • Elderly patients
    • Alcoholics
    • During contrast imaging (withhold temporarily)
  • Risk of lactic acidosisβ€”rare but potentially fatal

πŸ‘©β€βš•οΈ Patient Advice:

  • Take with evening meal (unless otherwise directed)
  • Do not crush or break the tablet
  • Inform doctor of any kidney, liver, or heart conditions
  • Monitor for unusual tiredness, breathing issues, or abdominal pain (lactic acidosis symptoms)
  • Regular blood tests to monitor sugar and kidney function
  • Maintain hydration
  • Avoid excessive alcohol intake
  • Inform your provider before any contrast scans or surgeries

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button